Progesterone’s protective effect may be attributed to PGR’s suppression of progesterone receptor membrane component-1 (PGRMC1), which increases the sensitivity of ovarian cancer cells to platinum-based chemotherapy [19]. This evidence concerns the gene PGR and ovarian carcinoma.